These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 1690659

  • 1. Several epitopes on native human complement C9 are involved in interaction with the C5b-8 complex and other C9 molecules.
    Kontermann R, Deppisch R, Rauterberg EW.
    Eur J Immunol; 1990 Mar; 20(3):623-8. PubMed ID: 1690659
    [Abstract] [Full Text] [Related]

  • 2. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
    Lehto T, Meri S.
    J Immunol; 1993 Nov 01; 151(9):4941-9. PubMed ID: 7691959
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
    Rollins SA, Zhao J, Ninomiya H, Sims PJ.
    J Immunol; 1991 Apr 01; 146(7):2345-51. PubMed ID: 1706395
    [Abstract] [Full Text] [Related]

  • 4. The role of the C9b domain in the binding of C9 molecules to EAC1-8 defined by monoclonal antibodies to C9.
    Yoden A, Moriyama T, Inoue K, Inai S.
    J Immunol; 1988 Apr 01; 140(7):2317-21. PubMed ID: 3351301
    [Abstract] [Full Text] [Related]

  • 5. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
    Rollins SA, Sims PJ.
    J Immunol; 1990 May 01; 144(9):3478-83. PubMed ID: 1691760
    [Abstract] [Full Text] [Related]

  • 6. Blood dendritic cells carry terminal complement complexes on their cell surface as detected by newly developed neoepitope-specific monoclonal antibodies.
    Würzner R, Xu H, Franzke A, Schulze M, Peters JH, Götze O.
    Immunology; 1991 Sep 01; 74(1):132-8. PubMed ID: 1718850
    [Abstract] [Full Text] [Related]

  • 7. Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity.
    Joiner KA, Warren KA, Tam M, Frank MM.
    J Immunol; 1985 May 01; 134(5):3411-9. PubMed ID: 3920319
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein.
    Podack ER, Preissner KT, Müller-Eberhard HJ.
    Acta Pathol Microbiol Immunol Scand Suppl; 1984 May 01; 284():89-96. PubMed ID: 6587746
    [Abstract] [Full Text] [Related]

  • 9. Analysis of C5b-8 binding sites in the C9 molecule using monoclonal antibodies: participation of two separate epitopes of C9 in C5b-8 binding.
    Hatanaka M, Seya T, Yoden A, Fukamoto K, Semba T, Inai S.
    Mol Immunol; 1992 May 01; 29(7-8):911-6. PubMed ID: 1378934
    [Abstract] [Full Text] [Related]

  • 10. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI, Jenkins DE, Leddy JP.
    J Immunol; 1985 Jan 01; 134(1):506-11. PubMed ID: 3964820
    [Abstract] [Full Text] [Related]

  • 11. Using polymerized C9 to produce a monoclonal antibody against a neoantigen of the human terminal complement complex.
    Kusunoki Y, Takekoshi Y, Nagasawa S.
    J Pharmacobiodyn; 1990 Jul 01; 13(7):454-60. PubMed ID: 2290128
    [Abstract] [Full Text] [Related]

  • 12. Role of a disulfide-bonded peptide loop within human complement C9 in the species-selectivity of complement inhibitor CD59.
    Husler T, Lockert DH, Sims PJ.
    Biochemistry; 1996 Mar 12; 35(10):3263-9. PubMed ID: 8605162
    [Abstract] [Full Text] [Related]

  • 13. Mapping of the complement C9 binding domain in paramyosin of the blood fluke Schistosoma mansoni.
    Deng J, Gold D, LoVerde PT, Fishelson Z.
    Int J Parasitol; 2007 Jan 12; 37(1):67-75. PubMed ID: 17123534
    [Abstract] [Full Text] [Related]

  • 14. The relationship between polymerization of complement component C9 and membrane channel formation.
    DiScipio RG.
    J Immunol; 1991 Dec 15; 147(12):4239-47. PubMed ID: 1721643
    [Abstract] [Full Text] [Related]

  • 15. A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9.
    Tomlinson S, Whitlow MB, Nussenzweig V.
    J Immunol; 1994 Feb 15; 152(4):1927-34. PubMed ID: 7509832
    [Abstract] [Full Text] [Related]

  • 16. Detection of refolding conformers of complement protein C9 during insertion into membranes.
    Laine RO, Esser AF.
    Nature; 1989 Sep 07; 341(6237):63-5. PubMed ID: 2475785
    [Abstract] [Full Text] [Related]

  • 17. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore.
    Bhakdi S, Tranum-Jensen J.
    J Immunol; 1986 Apr 15; 136(8):2999-3005. PubMed ID: 3958488
    [Abstract] [Full Text] [Related]

  • 18. On the cause and nature of C9-related heterogeneity of terminal complement complexes generated on target erythrocytes through the action of whole serum.
    Bhakdi S, Tranum-Jensen J.
    J Immunol; 1984 Sep 15; 133(3):1453-63. PubMed ID: 6747293
    [Abstract] [Full Text] [Related]

  • 19. Target deletion of complement component 9 attenuates antibody-mediated hemolysis and lipopolysaccharide (LPS)-induced acute shock in mice.
    Fu X, Ju J, Lin Z, Xiao W, Li X, Zhuang B, Zhang T, Ma X, Li X, Ma C, Su W, Wang Y, Qin X, Liang S.
    Sci Rep; 2016 Jul 22; 6():30239. PubMed ID: 27444648
    [Abstract] [Full Text] [Related]

  • 20. [Terminal complement complex (TTC) levels in plasma and urine from glomerular diseases: enzyme-linked immunosorbent assay (ELISA) using monoclonal antibody against neoantigens of TCC].
    Kusunoki Y.
    Hokkaido Igaku Zasshi; 1990 Jan 22; 65(1):74-85. PubMed ID: 2328949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.